Abstract. In 2005, Barthel, Royston, and Babiker presented a menu-driven Stata program under the generic name of ART (assessment of resources for trials) to calculate sample size and power for complex clinical trial designs with a time-toevent or binary outcome. In this article, we describe a Stata tool called ARTPEP, which is intended to project the power and events of a trial with a time-to-event outcome into the future given patient accrual figures so far and assumptions about event rates and other defining parameters. ARTPEP has been designed to work closely with the ART program and has an associated dialog box. We illustrate the use of ARTPEP with data from a phase III trial in esophageal cancer.
Introduction
presented a menu-driven Stata program under the generic name of ART (assessment of resources for trials) to calculate sample size and power for complex clinical trial designs with a time-to-event or binary outcome. Briefly, the features of ART include multiarm trials, dose-response trends, arbitrary failuretime distributions, nonproportional hazards, nonuniform rates of patient entry, loss to follow-up, and possible changes from allocated treatment. A full report on the methodology and its performance-in particular, regarding loss to follow-up, nonproportional hazards, and treatment crossover-is given by Barthel et al. (2006) .
In this article, we concentrate on a new tool that addresses a practical issue in trials with a time-to-event outcome. Because of staggered entry of patients and the gradual maturing of the data, the accumulation of events from the date the trial opens is a process that occurs over a relatively long period of time and with a variable course. Trials are planned and their resources are assigned under certain critical assumptions.
If those assumptions are unrealistic, timely completion of the trial may be threatened. Because the cumulative number of events is the key indicator of trial maturity and is the parameter targeted in the sample-size calculation, it is of considerable interest and relevance to monitor and project this number at particular points during the trial.
The new tool is called ARTPEP (ART projection of events and power). ARTPEP comprises an ado-file (artpep) and an associated dialog box. It works in conjunction with the ART system, of which the latest update is included with this article.
2 Example: A trial in advanced esophageal cancer 2.1 Sample-size calculation using ART
As an example, we describe sample-size calculation and ARTPEP analysis of a "typical" cancer trial. The OE05 trial in advanced esophageal carcinoma is coordinated by the MRC Clinical Trials Unit. The protocol is available online at http://www.ctu.mrc.ac.uk/ plugins/StudyDisplay/protocols/OE05%20Protocol%20Version%205%2031st%20July %202008.pdf. The design, which comprises two randomized groups of patients with equal allocation, aims to test the hypothesis that a new chemotherapy regimen, in conjunction with surgery, improves overall survival at 3 years.
According to the protocol, the probability of 3-year survival in this patient group is 30%, and the trial has 82% power at the 5% two-sided significance level to detect an improvement in overall survival to 38%. The overall sample size is stated to be 842 patients, and the required number of events is 673. The plan is to recruit patients over 6 years and to follow up with them for a further 2 years before performing the definitive analysis of the outcome (overall survival).
The description in the protocol provides nearly all the ingredients for an ART samplesize and power calculation. The only missing item is the target hazard ratio, which is ln (0.38) / ln (0.30) = 0.80 under proportional hazards of the treatment effect (a standard assumption). We first use the artsurv command (Barthel, Royston, and Babiker 2005) to verify the sample-size calculation and to set up some of the parameter values needed by ARTPEP. We supply the other design features, and then we run the artsurv command to compute the power and events:
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. artsurv, method(l) nperiod (8) ngroups (2) Apart from small, unimportant differences, the protocol power (0.82) and the number of events (673) are consistent with ART's results.
Analysis with ARTPEP
To run ARTPEP successfully, three preliminary steps are required:
1. You must activate the ART and ARTPEP items on the User menu by typing the command artmenu on.
2. You must compute the relevant sample size for the trial using either the ART dialog box or the artsurv command. This automatically sets up a global macro called $S ARTPEP whose contents are used by the artpep command. (A slightly more convenient alternative with the same result is to use the ART Settings... button on the ARTPEP dialog box to set up the necessary quantities for ART without having to run ART or artsurv separately.)
3. To set up additional parameters that ARTPEP needs, you must use the ARTPEP dialog box, either by typing db artpep or by selecting User > ART > Artpep from the menu.
As a worked example, we now imagine that the OE05 trial has been running for 1 year and has accrued 100 patients so far. Assuming the survival distribution to be correct, when may we expect to complete the trial (that is, obtain the required number of events)? To answer this question, we complete the three steps described above. The resulting empty dialog box is shown in figure 1. We now explain the various items that the dialog box needs. The name of the corresponding option for the artpep command is given in square brackets:
• ART Settings...: As already mentioned, this button may be used to set up the parameters of an ART run if that has not been done already. It accesses the ART dialog box.
• Patients recruited in each period so far [pts] : A "period" here is 1 year, and we have recruited 100 patients in the first period. We therefore enter 100 for this item.
• Additional patients to be recruited [epts] : To get to the 842 patients (we will use 850), we hope to recruit at about 150 patients per year for the next 5 years, making a total of 6 years' planned recruitment. We enter 150. The program knows the period in which recruitment is to cease and, by default, repeats the number 150 over the next 5 periods. If we had expected a differing recruitment rate (say, accelerating toward the end of the trial), we could have entered a different number of patients to be recruited in each period.
• Number of periods over which to project [eperiods] : Let us say we wish to project events and power over the next 10 years. We enter 10.
• Period in which recruitment cease [stoprecruit] : Here enter the number of periods after which recruitment is to cease. The number must be no smaller than the number of periods implied by Patients recruited in each period so far [pts] . If the option is left blank, it is assumed that recruitment continues indefinitely. As already noted, we wish to stop recruitment at 850 patients, which we will achieve by the end of period 6. We therefore enter 6 for this item.
• Period to start reporting projections [startperiod] : Usually, we want to enter 1 here, signifying the start of the trial. By default, if the item is left blank, the program assumes that the current period is intended. We enter 1.
• Save using filename [using] : The numerical results of the artpep run can be saved to a .dta file for a permanent record or for plotting. We leave the item blank.
•
Start date of trial (ddmmmyyyy) [datestart]:
If we enter the start date, the output from artpep is conveniently labeled with the calendar date of the end of each period. We recommend using this option. We enter 01jan2009.
The completed ARTPEP dialog box is shown in figure 2 . . artpep, pts(100) $S ARTPEP epts(150) eperiods (10) The program reports the total number of events (#events) and the number of events in the control arm (#C-events), which are often of interest. The required total number of events (that is, both arms combined) of 673 is projected to be reached on 31 December 2016, the end of period 8. We expect 351 events in the control arm by that time. The projection is not surprising because the accrual figures that have been entered more or less agree with the trial plan. Nevertheless, the output shows us the expected progress of the number of events and the power over time. The trial may be monitored (and the ARTPEP analysis updated) to follow its progress.
The dialog box has, as usual, created and run the necessary artpep command line. The second item in the command is $S ARTPEP. As already mentioned, it contains additional information needed by artpep. On displaying its contents, we find . display "$S ARTPEP" alpha(.05) aratios() hratio(1, 0.80) ngroups (2) ni (0) onesided (0) The key pieces of information here are hratio(1, 0.80) and edf0(0.3, 3), which specify the hazard ratios in groups 1 and 2, and the survival function in group 1, respectively. All the other items are default values and could be omitted in the present example. The present example could have been run directly from the command line as follows:
. artpep, pts(100) edf0(0.3, 3) epts(150) eperiods(10) startperiod(1) > stoprecruit(6) datestart(01jan2009) hratio(1, 0.8)
Sensitivity analysis of the event rate
We have assumed a 30% survival probability 3 years after recruitment. Suppose, in fact, that the patients do better than that-their 3-year survival is 40% instead. What effect would that have on the power and events timeline?
We need only change the edf0() option to edf0(0.4, 3):
. artpep, pts(100) epts(150) edf0(0.4, 3) eperiods(10) startperiod(1) > stoprecruit(6) datestart (01jan2009) The time to observe the required number of events has advanced by more than 1 year, to period 9 (31dec2017).
Syntax
Once you have gained a little experience with using the ARTPEP dialog box, you will find it more natural and efficient to use the command line. The syntax of artpep is as follows:
artpep using filename , pts(numlist) edf0(slist0) epts(numlist)
replace artsurv options 4 Options pts(numlist) is required. numlist specifies the number of patients recruited in each period since the start of the trial, that is, since randomization. See help on artsurv for the definition of a "period". The number of items in numlist defines the number of periods of recruitment so far. For example, pts(23 12 25) specifies three initial periods of recruitment, with recruitment of 23 patients in period 1, 12 in period 2, and 25 in period 3. The "current" period would be period 3 and would be demarcated by parallel lines in the output.
edf0 (slist0 ) is required and gives the survival function in the control group (group 1). This need not be one of the survival distributions to be compared in the trial, unless hratio() = 1 for at least one of the groups. The format of slist0 is #1 [#2 . . . #r, #1 #2 . . . #r]. Thus edf0(p 1 p 2 . . . p r , t 1 t 2 . . . t r ) gives the value p i for the survival function for the event time at the end of time period t i , i = 1, . . . , r. Instantaneous event rates (that is, hazards) are assumed constant within time periods; that is, the distribution of time-to-event is assumed to be piecewise exponential. When used in a given calculation up to period T , t r may validly be less than, equal to, or greater than T . If t r ≤ T , the rules described in the edf0() option of artsurv are applied to compute the survival function at all periods ≤ T . If t r > T , the same calculation is used but estimated survival probabilities for periods > T are not used in the calculation at T , although they may of course be used in calculations (for example, projections of sample size and events) for periods later than T . Be aware that use of the median() option (an alternative to edf0()) and the fp() option of artsurv may modify the effects and interpretation of edf0().
epts(numlist) specifies in numlist the number of additional patients to be recruited in each period following the recruitment phase defined by the pts() option. For example, pts(23 12 25) epts(30 30) would specify three initial periods of recruitment followed by two further periods. A projection of events and power is required over the two further periods. The initial recruitment is of 23 patients in period 1, 12 in period 2, and 25 in period 3; in each of periods 4 and 5, we expect to recruit an additional 30 patients. If the number of items in (or implied by expanding) numlist is less than that specified by pts(), the final value in numlist is replicated as necessary to all subsequent periods. If epts() is not given, the default is that the mean of the numbers of patients specified in pts() is used for all projections.
eperiods(#) specifies the number of future periods over which projection of power and number of events is to be calculated. The default is eperiods(1).
stoprecruit(#) specifies the number of periods after which recruitment is to cease. # must be no smaller than the number of periods of recruitment implied by pts(). The default is stoprecruit(0), meaning to continue recruiting indefinitely (no follow-up phase).
startperiod(#) specifies # as the period in which to start reporting the projections of events and power. To report from the beginning of the trial, specify startperiod(1). Note that startperiod() does not affect the period at which the calculations are started, only how the results are reported. The default # is the last period defined by pts().
datestart(ddmmmyyyy) signifies the opening date of the trial (that is, when recruitment started), for example, datestart(14oct2009). The date of the end of each period is used to label the output and is stored in filename if using is specified.
replace allows filename to be replaced if it already exists.
artsurv options are any of the options of artsurv except recrt(), nperiod(), power(), and n().
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